Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
30.3M
-
Shares change
-
+1.11M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$38.1M
-
Put/Call ratio
-
12.07
-
Number of buys
-
118
-
Number of sells
-
-82
-
Price
-
$34.79
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2022
236 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2022.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.3M shares
of 46.4M outstanding shares and own 65.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.07M shares), FEDERATED HERMES, INC. (3.28M shares), VANGUARD GROUP INC (2.56M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), STATE STREET CORP (1.54M shares), MORGAN STANLEY (827K shares), FULLER & THALER ASSET MANAGEMENT, INC. (727K shares), GEODE CAPITAL MANAGEMENT, LLC (692K shares), Nuveen Asset Management, LLC (591K shares), and Invesco Ltd. (510K shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.